USANA
This article was originally published in The Tan Sheet
Executive Summary
Firm announces plans to begin operations in Singapore in Q4 2003. "Singapore represents a strategic location for future expansion throughout Southeast Asia," USANA Pres. Dave Wentz says. The Salt Lake City, Utah-based company presently operates in eight countries outside the U.S. including South Korea and Japan (1"The Tan Sheet" July 21, 2003, p. 13)...
You may also be interested in...
USANA Using “Backwash” Strategy To Enter New Markets, Boost Sales
USANA Health Sciences is leveraging entrance into new markets to spur sales in existing ones as part of its business strategy to grow the top line
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.